Thu, 25 Jul 2019 07:14:43 GMT
AstraZeneca raises sales forecast after Q2 cancer drug boost
AstraZeneca has raised its sales estimates for 2019 by a low double-digit percentag, boosted by cancer medicine sales, including Tagrisso treatment's almost doubling results, according to Reuters.